Company Profile

Since 1996, Coris BioConcept has been developing, manufacturing and marketing rapid in vitro diagnostic solutions for infectious diseases.

Based in Belgium, the company serves healthcare professionals in more than 80 countries worldwide.

AntiMicrobial Resistance (AMR) detection is at the heart of Coris BioConcept’s portfolio, with rapid assays designed to identify major antibiotic resistance mechanisms.

The company also offers diagnostic solutions for respiratory and gastrointestinal infections, enabling the detection of key bacterial, viral and parasitic pathogens.

To expand its diagnostic offering, Coris BioConcept launched the DIAGENTIS range, providing PCR-based molecular assays that complement its rapid tests.

Combining expertise in immunochromatography, ELISA and molecular technologies, Coris BioConcept delivers reliable and user-friendly diagnostic solutions.

The company also offers CDMO services for in vitro diagnostics, from assay development to commercial manufacturing.

All products are developed and manufactured under ISO 13485 and IVDR-compliant quality systems.

Coris BioConcept is part of the 3B BlackBio Dx Ltd. group.